Evolution of Therapies for Chronic Myelogenous Leukemia

Cancer Journal - United States
doi 10.1097/ppo.0b013e31823dec8d
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Chronic Myelogenous Leukemia

Journal of the National Comprehensive Cancer Network : JNCCN
MedicineOncology
2012English

Chronic Myelogenous Leukemia Molecular Signature

Oncogene
Cancer ResearchGeneticsMolecular Biology
2003English

Erythroid Variant of Chronic Myelogenous Leukemia

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2007English

Immunological Studies on Chronic Myelogenous Leukemia

Okayama Igakkai Zasshi (Journal of Okayama Medical Association)
1976English

Sweet's Syndrome After Splenic Irradiation for Chronic Myelogenous Leukemia

Journal of the American Osteopathic Association, The
MedicineAlternative MedicineComplementary
1996English

Pharmacotherapy for Chronic Myelogenous Leukemia: A Case-Based Approach

Journal of the National Comprehensive Cancer Network : JNCCN
MedicineOncology
2011English

Thrombotic Thrombocytopenic Purpura in Chronic Myelogenous Leukemia

Canadian Journal of Ophthalmology
MedicineOphthalmology
2020English

Bosutinib in the Management of Chronic Myelogenous Leukemia

Biologics: Targets and Therapy
OncologyImmunologyGastroenterologyPharmacologyRheumatologyAllergy
2013English

Heterogeneity of Leukemia-Initiating Capacity of Chronic Myelogenous Leukemia Stem Cells

Journal of Clinical Investigation
Medicine
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy